Andere Kunden interessierten sich auch für
![Development and Optimization of Thermosensitive gel of Metoprolol]( "Development and Optimization of Thermosensitive gel of Metoprolol")
Development and Optimization of Thermosensitive gel of Metoprolol42,99 €![Micronized carvedilol SR matrix tablet for imporved dissolution]( "Micronized carvedilol SR matrix tablet for imporved dissolution")
Micronized carvedilol SR matrix tablet for imporved dissolution23,99 €![Development and optimization of novel controlled-release micropellets]( "Development and optimization of novel controlled-release micropellets")
Development and optimization of novel controlled-release micropellets32,99 €![Development and optimization of press coated tablet of Carvedilol]( "Development and optimization of press coated tablet of Carvedilol")
Development and optimization of press coated tablet of Carvedilol38,99 €![Factorial Design Approach as a Tool of Optimization Methodology]( "Factorial Design Approach as a Tool of Optimization Methodology")
Factorial Design Approach as a Tool of Optimization Methodology26,99 €![Formulation and optimization of floating matrix tablets of salbutamol]( "Formulation and optimization of floating matrix tablets of salbutamol")
Formulation and optimization of floating matrix tablets of salbutamol26,99 €![Designing of Oral Sustained Release Bioadhesive Drug Delivery System]( "Designing of Oral Sustained Release Bioadhesive Drug Delivery System")
Designing of Oral Sustained Release Bioadhesive Drug Delivery System57,99 €
The purpose of this book will to prepare Pyridostigmine nanoparticles for control release of Pyridostigmine to improve the oral bioavailability, enhance the solubility and dissolution rate by decreasing particle size of drug. Infrared spectroscopic studies confirmed that there was no interaction between drug and polymers. The controlled release Pyridostigmine nanoparticles were prepared by Solvent evaporation by using Ethyl cellulose, Chitosan & HPMC K100 at different ratios. The production yield of the formulated controlled release nanoparticles (F1 to F16) in the range of 76.11 % to 83.58 %. The drug content of the formulated controlled release nanoparticles (F1 to F16) in the range of 82.56 %to 98.20%. The Theoretical loading of the formulated controlled release nanoparticles (F1- F16) in the range of 24.43 % to 64.24%. The entrapment efficiency increased with increasing the concentration of polymers and the formulations containing chitosan nanoparticles F6 (1:2) showed betterentrapment (90.94%) among all formulation.